Lethal variant in the C2A domain may cause severe SYT1-associated neurodevelopmental disorder in the newborns
Authors:
- 6 November 2023
- journal article
- research article
- Published by Springer Nature in neurogenetics
- Vol. 25 (1) , 27-31
Abstract
Synaptotagmin-1 (SYT1) plays a pivotal role in regulating presynaptic processes, including neurotransmitter release. SYT1 variants perturb synaptic vesicle endocytosis and exocytosis, resulting in a series of neurodevelopmental disorders defined as Baker-Gordon syndrome. Herein, we report the case of a newborn with dysmorphic facial appearance, severe hypotonia, poor feeding, gastroesophageal reflux, and an inability to eat and breathe, diagnosed with Baker–Gordon syndrome. A retrospective search was performed on a newborn with Baker-Gordon syndrome. Medical charts were reviewed, with focus on the clinical presentation, diagnostic process, and treatment outcomes. Whole-genome high-throughput DNA sequencing was performed to identify genetic variants. Whole-exome sequencing identified the likely pathogenic variant as SYT1 C.551 T > C(p.V184A). Sanger sequencing results indicated that this variant was a de novo mutation in a conservative site located in the C2A domain of the protein. The patient died at 57 days old because of severe feeding and breathing problems. Our findings of a novel lethal variant in the C2A domain of SYT1 in the youngest patient diagnosed infantile Baker-Gordon syndrome who presented with the most severe hypotonia reported to date expands the spectrum of SYT1- associated neurodevelopmental disorders.Keywords
Funding Information
- Xi'an Children Hospital (2021H05)
This publication has 11 references indexed in Scilit:
- Synaptotagmin-1 membrane binding is driven by the C2B domain and assisted cooperatively by the C2A domainScientific Reports, 2020
- The neurodevelopmental spectrum of synaptic vesicle cycling disordersJournal of Neurochemistry, 2020
- Molecular Basis for Synaptotagmin-1-Associated Neurodevelopmental DisorderNeuron, 2020
- SYT1-associated neurodevelopmental disorder: a case seriesBrain, 2018
- Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndromeEuropean Journal of Human Genetics, 2015
- Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cyclingJournal of Clinical Investigation, 2015
- Neurotransmitter Release: The Last Millisecond in the Life of a Synaptic VesicleNeuron, 2013
- Genetic Analysis of Synaptotagmin C2 Domain Specificity in Regulating Spontaneous and Evoked Neurotransmitter ReleaseJournal of Neuroscience, 2013
- Differential but convergent functions of Ca 2+ binding to synaptotagmin-1 C 2 domains mediate neurotransmitter releaseProceedings of the National Academy of Sciences, 2009
- C2A activates a cryptic Ca 2+ -triggered membrane penetration activity within the C2B domain of synaptotagmin IProceedings of the National Academy of Sciences, 2002